Category: Wall Street BeatSyndicate content

HCA hospitals halt use of uterine fibroid surgical tool

November 25, 2014 by MassDevice

HCA Holdings halts the use of laparoscopic power morcellators in uterine fibroid surgeries in all 278 of its facilities, after the FDA raises the warning level on the cancer risk associated with the devices.

HCA hospitals halt use of uterine fibroid surgical tool

(Reuters) — HCA Holdings (NYSE:HCA), the largest for-profit U.S. hospital operator, said a procedure for removing uterine fibroids that's been linked to the spread of cancer will no longer be performed at its facilities.

Medtronic expects to free up to $4B after IRS beef is settled

November 25, 2014 by Brad Perriello

Medtronic says it expects to repatriate as much as $4 billion in cash after it resolves a dispute with the IRS involving its Puerto Rico subsidiary.

Medtronic expects to free up to $4B after IRS beef is settled

Medtronic (NYSE:MDT) said today that it expects to land a substantial windfall once it resolves a dispute with the IRS over the next "couple of years."

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.

Will Stryker bid on Smith & Nephew this week?

UPDATED Nov. 24 with analysis from Morgan Stanley.

Second Sight CEO Greenberg: Next-gen 'bionic eye' could treat nearly all forms of blindness

November 20, 2014 by Brad Perriello

Second Sight Medical, which yesterday saw its initial public offering close up nearly 122%, could have its next-generation 'bionic eye' device ready for nearly all blind patients 'within a couple of years,' CEO Dr. Robert Greenberg tells MassDevice.com.

Second Sight Medical CEO Greenberg: Next-gen bionic eye could treat nearly all forms of blindness

Shares soar for InVivo after spinal cord study update | Medtech Wall Street news for the week of November 17, 2014

November 20, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: InVivo shares soar on spinal cord study update; Actavis trumps Valeant with $66B offer for Allergan; Medtronic's Q2 results meet The Street; Venture capital investment in medtech grows in Q3

InVivo shares soar on spinal cord study update

November 13, 2014 by Val Kennedy

Cardica plunges after pulling MicroCutter Xchange 30 stapler

November 19, 2014 by Val Kennedy

Cardica shares plunge after it suspends the launch of its MicroCutter Xchange 30 surgical stapler so it can focus on improving the product, a move that may also result in a realignment of its operations.

Cardica plunges after pulling MicroCutter Xchange 30 stapler

Venture capital investment in medtech grows in Q3

November 18, 2014 by Brad Perriello

Venture capital investment in medical device companies rose in terms of both value and volume during the 3rd quarter, compared with the same period last year, according to PricewaterhouseCoopers.

Venture capital investment in medtech grows in Q3

Venture capitalists put more cash into more deals for medical device companies during the 3rd quarter, according to a report from PricewaterhouseCoopers.

Medical device companies pulled down $586 million in 78 deals during the 3rd quarter, up 13% in dollars and 18% in deal volume compared with Q3 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp